Intellia Therapeutics, Inc. (NTLA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$12.74+0.47%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NTLA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 59.5 | 67.7 | 57.9 | 36.3 | 52.1 | 33.1 | 58.0 | 43.1 | 30.4 | — | — |
| Cost of Revenues | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 346.7 | 388.9 | 466.3 | 435.1 | 420.0 | 229.8 | 150.4 | 108.4 | 89.1 | 67.6 | 31.8 |
| Operating Income | (423.5) | (441.0) | (534.3) | (515.3) | (458.2) | (267.9) | (136.6) | (106.4) | (90.9) | (69.6) | (32.2) |
| Earnings from Continuing Operations | |||||||||||
| Interest & Investment Income | 24.2 | 29.2 | 47.8 | 49.8 | 8.5 | 1.3 | 2.4 | 6.8 | 5.5 | 2.0 | 0.5 |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | (67.5) | (31.6) |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | (1.0) | 0.0 |
| Net Income | |||||||||||
| Net Income | (400.0) | (412.7) | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (474.2) | (85.3) | (67.5) | (31.6) |
| Per Share | |||||||||||
| Basic EPS | (3.00) | (3.81) | (5.25) | (5.42) | (6.16) | (3.78) | (2.40) | — | — | — | — |
| Diluted EPS | (3.00) | (3.81) | (5.25) | (5.42) | (6.16) | (3.78) | (2.40) | — | — | — | — |
| Revenue per Share | 0.45 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 133.5 | 108.4 | 98.8 | 88.8 | 77.0 | 70.9 | 56.0 | — | — | — | — |
| Diluted Weighted Avg Shares | 133.5 | 108.4 | 98.8 | 88.8 | 77.0 | 70.9 | 56.0 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (431.2) | (524.0) | (506.3) | (450.6) | (261.0) | (130.3) | (100.8) | (86.4) | (66.6) | — |
| EBIT | (423.5) | (441.0) | (534.3) | (515.3) | (458.2) | (267.9) | (136.6) | (106.4) | (90.9) | (69.6) | (32.2) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | 1.5% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.